Tania C. Jorge-De Araujo

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Transcriptome Analysis of Circulating microRNAs Associated With Chagas Disease Susceptibility and Chronic Chagas Cardiomyopathy Severity.

Transcriptome Analysis of Circulating microRNAs Associated With Chagas Disease Susceptibility and Chronic Chagas Cardiomyopathy Severity.

Journal: The Journal of infectious diseases

Published: September 02, 2025

A decade of innovation to deepen the understanding of infectious diseases of poverty and foster their control and elimination.

A decade of innovation to deepen the understanding of infectious diseases of poverty and foster their control and elimination.

Journal: Infectious diseases of poverty

Published: October 24, 2022

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance.

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance.

Journal: Frontiers in cellular and infection microbiology

Published: August 11, 2022

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice.

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice.

Journal: Scientific reports

Published: July 29, 2022

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease.

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease.

Journal: Memorias do Instituto Oswaldo Cruz

Published: December 17, 2021

CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.

CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.

Journal: PLoS neglected tropical diseases

Published: May 08, 2020

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.

Journal: PLoS neglected tropical diseases

Published: February 04, 2019

TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection.

TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection.

Journal: Parasitology

Published: March 22, 2016

Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease.

Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease.

Journal: Immunobiology

Published: December 04, 2015

Use of haloperidol and risperidone in highly aggressive Swiss Webster mice by applying the model of spontaneous aggression (MSA).

Use of haloperidol and risperidone in highly aggressive Swiss Webster mice by applying the model of spontaneous aggression (MSA).

Journal: Behavioural brain research

Published: August 31, 2015

Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial.

Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial.

Journal: Trials

Published: June 23, 2014

Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.

Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.

Journal: Cytokine & growth factor reviews

Published: October 22, 2008

Showing 1-12 of 14

Last Updated: 09/26/2026